Alvaro Galvez Lima
Surgery · Allentown, PANPI 1336555655
Payments from drug & device makers
Across 98 payments — averaging $152.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$12K
- Johnson & Johnson$1K
- W. L. Gore & Associates, Inc.$811
- Medtronic$609
- Novo Nordisk$233
- Mozarc Medical US LLC$100
- plus $250 from 5 others
What the payments were for
- Travel & lodging$5,29935%
- Food & beverage$5,15434%
- Education$4,50030%
- Gifts$140%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Intuitive Surgical | 52 | $11,900 |
| Johnson & Johnson | 11 | $1,065 |
| W. L. Gore & Associates, Inc. | 7 | $811 |
| Medtronic | 5 | $609 |
| Novo Nordisk | 13 | $233 |
| Mozarc Medical US LLC | 1 | $100 |
| Lilly USA, LLC | 5 | $88 |
| Boston Scientific | 1 | $72 |
| Medical Device Business Services, Inc. | 1 | $46 |
| Baxter Healthcare | 1 | $28 |
| Phathom Pharmaceuticals, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Da Vinci Surgical System$9,461
- DAVINCI XI$1,000
- DA VINCI SP$745
- GORE SEAMGUARD Bioabsorbable Staple Line Reinforce$503
- Barrx$295
- Enseal$272
- Echelon Endopath Staple Line Reinforcement$235
- Surgicel Powder$235
- LINX Reflux Management System$233
- Signia$168
- Echelon Flex$124
- STRATAFIX$124
- Harmonic$124
- HARMONIC Product Family$123
- GORE ENFORM Preperitoneal Biomaterial$119
- Argyle$100
How this compares
$14,967 in reported general payments places this provider in the 90th percentile of 1,424 surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Omeprazole | 88 | $697 |
| Ondansetron OdtOndansetron | 20 | $526 |
| Dexamethasone | 11 | $92 |
| Topiramate | 20 | $80 |
| Tramadol Hcl | 28 | $60 |
Paid to pharmacies, not to this prescriber.
Other surgery in Allentown
- Maher El ChaarAllentown$667K
- Paul CesanekAllentown$469K
- Scott BemanAllentown$56K
- Giorgos KarakousisPhiladelphia$8.8M
- James MarkmannPhiladelphia$1.8M
- John MiuraPhiladelphia$1.3M
- Martin WijkstromPittsburgh$1.3M
- Andy KiserPittsburgh$1.1M
- Blair JobePittsburgh$827K
- Glenn SteeleDanville$698K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.